Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 67Pancreatic Neoplasms 34Neoplasm Metastasis 22Neuroblastoma 21Neoplasms 16Colonic Neoplasms 15Stomach Neoplasms 13Rectal Neoplasms 13Sarcoma, Ewing 8Rhabdomyosarcoma 8Esophageal Squamous Cell Carcinoma 8Small Cell Lung Carcinoma 7Sarcoma 7Ovarian Neoplasms 6Lung Neoplasms 6Cholangiocarcinoma 6Esophageal Neoplasms 5Breast Neoplasms 5Adenocarcinoma Of Esophagus 5Medulloblastoma 4Gastrointestinal Neoplasms 4Endometrial Neoplasms 4Biliary Tract Neoplasms 4Adenocarcinoma 4Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Osteosarcoma 3Glioma 3Glioblastoma 3Ganglioneuroblastoma 3

Interventions

Bevacizumab 2trifluridine tipiracil drug combination 1gadolinium ethoxybenzyl DTPA 1gadobutrol 1encorafenib 1durvalumab 1Urine Specimen Collection 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Oxaliplatin 1Oviposition 1Nivolumab 1Levoleucovorin 1Leucovorin 1Irinotecan 1Immunotherapy 1IDRX-42 1Hydromorphone 1Fluorouracil 1Fentanyl 1Drug Therapy 1Drainage 1Dietary Supplements 1Colonoscopy 1Cetuximab 1Capecitabine 1Bupivacaine 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Diseases × Irinotecan × 1 year × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡